NORMOTHERMIC EXTRACORPOREAL PERFUSION IN SITU IN DECEASED ORGAN DONORS WITH IRREVERSIBLE CARDIAC ARREST AND ONE HOUR OF ASYSTOLE. 5-YEAR OUTCOMES OF KIDNEY TRANSPLANTATION

Aim. The global shortage of deceased organ donors caused increasing interest to the transplant program based on the use of organs from the donors with sudden irreversible cardiac arrest, or asystolic donors (DCD). Ischemia-reperfusion injury as a result of cardiac arrest remains a key problem that limits the use of organs from DCD. Our clinical study was intended to determine the acceptability of renal transplants derived from the DCD using extracorporeal perfusion in situ after 60 minutes of asystole. Materials and methods. In 2009–2014, St. Petersburg Organ Procurement Organization (OPO) obtained kidneys from 29 DCD with critically expanded warm ischemic time (WIT). The design of this study was approved by the Scientifi c Board and Ethics Committee of the State Research Institute for Emergency Medicine (Decision 7/0615/09). Initially, no one of died patients was considered as potential organ donors. In case of failed advanced CPR the death of a patient was declared initiating the protocol of subnormothermic extracorporeal abdominal perfusion with ECMO, thrombolytics (strepokinase 1.5 mln U), and LD. The procedures were established by the authorized OPO team which arrived with perfusion equipment in 30–40 minutes after declaration of donors’ death. Mean WIT was 58.1 (19.39) minutes (Mean (SD). Resuscitated grafts were transplanted into 58 recipients. The outcomes of transplantation of resuscitated kidneys were compared to those of 112 KTx from 115 brain death donors (BDDs). Results. Immediate functioning of kidney grafts was observed in 28 (48.3%) of 58 recipients. There were 4 cases of primary graft non-function. By the end of the fi rst post-transplant year there was an acute rejection rate of 12.1% (9 episodes of rejection) in the DCD group vs. 23.2% (26 episodes of rejection) in the BDD group (p < 0.05). The actuarial 5-year graft survival rate was 82.8% (n = 48) in DCD group, and 87.5% (n = 98) in BDD group (p > 0.05). Creatinine levels at the end of the fi fth year were 0.094 (0.06) and 0.103 (0.07) mmol/l in DCD and BDD groups, respectively (p > 0.05). Conclusions. Kidneys from DCDs with critically expanded WIT could be successfully used for transplantation if in situ organ “resuscitation” perfusion procedures are included into procurement protocol. The 5-year outcomes meet the generally accepted criteria for grafts’ and recipients’ rates of survival and functioning. This approach could substantially expand the organ donors’ pool. 

1. Органное донорство и трансплантация в Российской Федерации в 2013 году (VI сообщение национального регистра Российского трансплантологического общества). Трансплантология: итоги и перспективы. Том V. 2013 год / Под ред. С.В. Готье. М.–Тверь: Триада, 2014: 352, 32–57. Organ donation and transplantation in Russian Federation in 2014 (VI report of National Registry). Transplantology: results and prospects. Vol. V. 2013 / ed. by S.V. Gautier. M.–Tver: Triad, 2014: 352, 32–57.

2. Донорство и трансплантация органов в Российской Федерации в 2014 году (VII сообщение национального регистра Российского трансплантологического общества). Трансплантология: итоги и перспективы. Том VI. 2014 год / Под ред. С.В. Готье. М.– Тверь: Триада, 2015; 488, 44–75. Organ donation and transplantation in Russian Federation in 2015 (VII re￾port of National Registry). Transplantology: results and prospects. Vol. VI. 2014 / ed. by S.V. Gautier. M.–Tver: Triad, 2015: 488, 44–75.

3. Погребниченко ИВ, Мойсюк ЯГ, Резник ОН. Есть ли законные основания для участия стационаров в программах органного донорства? Здравоохранение. 2012; 1: 40–48. Pogrebnichenko IV, Moysyuk YaG, Reznik ON. Est li zakonnyie osnovaniya dlya uchastiya statsionarov v programmah organnogo donorstva? Zdravoohranenie. 2012; 1: 40–48.

4. Распоряжение Комитета здравоохранения Санкт- Петербурга № 672-р от 11.08.14 г. «О совершенствовании организации органного донорства в Санкт-Петербурге». Rasporyazheniye Komiteta zdravoohraneniya Sankt-Peterburga № 672-r ot 11.08.14 g. «O sovershenstvovanii organizacii organnogo donorstva v Sankt-Peterburge».

5. Багненко СФ, Полушин ЮС, Мойсюк ЯГ, Минина МГ, Логинов ИВ, Погребниченко ИВ, Резник ОН. Анализ причин дефицита доноров органов и основные направления его преодоления. Трансплантология. 2011; 2 (3): 10–23. Bagnenko SF, Polushin YuS, Moysyuk YaG, Minina MG, Loginov IV, Pogrebnichenko IV, Reznik ON. Analiz prichin defi tsita donorov organov i osnovnyie napravleniya ego preodoleniya. Transplantologiya. 2011; 2 (3): 10–23.

6. Багненко СФ, Резник ОН, Мойсюк ЯГ, Погребниченко ИВ. Перспективы развития органного донорства. Здравоохранение. 2011; 11: 40–47. Bagnenko SF, Reznik ON, Moysyuk YaG, Pogrebnichenko IV. Perspektivy razvitiya organnogo donorstva. Zdravoohranenie. 2011; 11: 40–47.

7. http://www.UNOS.org, доступ 16.03.2016.

8. http://www.eurotransplant.org/, доступ 16.03.2016.

9. Багненко СФ, Логинов ИВ, Резник ОН. Причины дефицита донорских органов и пути его преодоления. Медицинский академический журнал. 2011; 4 (11): 13–25. Bagnenko SF, Loginov IV, Reznik ON. Prichiny defi cita donorskih organov i puti ego preodoleniya. Medicinskij akademicheskij zhurnal. 2011; 4 (11): 13–25.

10. Rozenthal R. Organ Donation: Quo vadis? Annals of Transplantation. 2006; 11 (3): 49–51. 11. Hanto DW, Veatch RM. Uncontrolled donation after circulatory determination of death (UDCDD) and the defi - nition of death. Am. J. Transplant. 2011; 11 (7): 1351– 1352. doi: 10.1111/j.1600-6143.2011.03583.x.

11. Mone TD. The business of organ procurement. Curr. Opinion in Organ Transplant. 2002; 7: 60–64.

12. van Dijk G, Giezeman A, Ultee F, Hamers R. Organ do￾nation after active euthanasia in a patient with a neurodegenerative disease. Ned Tijdschr Geneeskd. 2013; 157 (39): A6548. PMID: 24063672.

13. Domínguez-Gil B, Delmonico FL, Faissal AM Shaheen et al. The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation. Transplant International a 2011 European Society for Organ Transplantation. 2011; 24: 373–378.

14. Domínguez-Gil B, Haase-Kromwijk B, Van Leiden H. Current situation of donation after circulatory death in European countries. Transpl. Int. 2011; 24 (7): 676–686. doi: 10.1111/j.1432-2277.2011.01257.x.

15. Bramhall S. Presumed consent for organ donation: a case against. Ann. R. Coll. Surg. Engl. 2011 May; 93 (4): 270– 272. doi: 10.1308/147870811X571136b.

16. White SL, Leichtman AB, O’Connor K, Lipkowitz G, Pietroski R, Stoff JS et al. Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilization. Transplant Proc. 2012 Sep; 44 (7): 2223–2226. doi: 10.1016/j.transproceed.2012.07.103.

17. Sung RS, Christensen LL, Leichtman AB, Greenstein SM, Distant DA, Wynn JJ et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am. J. Transplant. 2008 Apr; 8 (4): 783–792. doi: 10.1111/j.1600-6143.2008.02157.x. Epub 2008 Feb 19.

18. Manara AR, Murphy PG, O’Callaghan G. Donation after circulatory death. Br. J. Anaesth. 2012; 108 (1): 1108–1121. doi: 10.1093/bja/aer357.

19. Garcia CE, Bramhall S, Mirza DF. Use of marginal do￾nors. Current Opinion in Organ Transplantation. 2000; 5: 50–56.

20. Reznik ON, Bagnenko SF, Skvortsov AE et al. Rehabilitation of Ischemically Damaged Human Kidneys by Normothermic Extracorporal Hemoperfusion in situ With Oxygenation and Leukocyte Depletion. Transplantation proceedings. 2010; 42 (5): 1536–1538.

21. Reznik ON, Bagnenko SF, Skvortsov AE. Uncontrolled Donors with Controlled Reperfusion after Sixty Minutes of Asystole: A Novel Reliable Resource for Kidney Transplantation. PloS One. 2013; 8 (5): e64209.

22. James FC, Catharyn TL. Organ Donation: Opportunities for Action // Institute of Medicine (U.S.). Committee on Increasing Rates of Organ Donation. 2006.

23. Xu H, Wang D, Peng C, Huang X, Ou M, Wang N et al. Rabbit sera containing compound danshen dripping pill attenuate leukocytes adhesion to TNF-alpha – activated human umbilical vein endothelial cells by suppressing endothelial ICAM-1 and VCAM-1 expression through NF-kappaB signaling pathway. J. Cardiovasc. Pharmacol. 2014 Apr; 63 (4): 323–332. doi: 10.1097/ FJC.0000000000000046.

24. Toledo-Pereyra LH. Leukocyte depletion, ischemic injury, and organ preservation. J. of Surg. Research. 2011; 169 (2): 188–189. doi: 10.1016/j.jss.2010.09.048.

25. Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z. Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat. Mol Pharm. 2014 Oct 6; 11 (10): 3503– 3514. doi: 10.1021/mp500282g. Epub 2014 Aug 25.

26. Duehrkop C, Rieben R. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specifi c complement inhibition. Biochem. Pharmacol. 2014 Mar 1; 88 (1): 12–22. doi: 10.1016/j. bcp.2013.12.013. Epub 2013 Dec 30. Review.

27. Durandy Y. Warm pediatric cardiac surgery: European experience. Asian Cardiovasc. Thorac. Ann. 2010; 18 (4): 386–395. doi: 10.1177/0218492310376675.

28. Fan Y, Zhang AM, Xiao YB. Warm versus cold cardioplegia for heart surgery: a meta-analysis. Eur. J. Cardiothorac. Surg. 2010; 37 (4): 912–919. doi: 10.1016/j. ejcts.2009.09.030.

29. Jacob S, Kallikourdis A, Sellke F. Is blood cardioplegia superior to crystalloid cardioplegia? Interact. Cardiovasc. Thorac. Surg. 2008; 7 (3): 491–498. doi: 10.1510/ icvts.2008.178343.

30. Одинак ММ, Вознюк ИА, Янишевский СН, Голохвастов СЮ, Фокин ВА. Острый церебральный тромбоз – реканализация за пределами окна тромболитической терапии. Дисфункция эндотелия. Патогенетическое значение и методы коррекции; под ред. Н.Н. Петрищева. СПб.: ВМедА, 2007: 121–139. Odinak MM, Voznyuk IA, Yanishevskij SN, Golohvastov SYu, Fokin VA. Ostryj cerebral’nyj tromboz – rekanalizaciya za predelami okna tromboliticheskoj terapii. Disfunkciya ehndoteliya. Patogeneticheskoe znachenie i metody korrekcii; pod red. N.N. Petrishcheva. SPb.: VMedA, 2007: 121– 139.

31. Одинак ММ, Вознюк ИА, Кузнецов АН, Есипова ОГ. Возможности реопозитивной терапии при острой ишемии головного мозга. Регионарное кровообращение и микроциркуляция. 2003; 2 (1): 21–27. Odinak MM, Voznyuk IA, Kuznecov AN, Esipova OG. Vozmozhnosti reopozitivnoj terapii pri ostroj ishemii golovnogo mozga. Regionarnoe krovoobrashchenie i mikrocirkulyaciya. 2003; 2 (1): 21–27.